Cardiovascular

Latest News

AJMC
Impact of Functional Recovery on Patients Having Heart Surgery

October 10th 2024

This article describes the positive impact that actively managing functional recovery has on postacute placement for patients undergoing coronary artery bypass surgery.

doc measuring BP in pregnant woman-Andrey Popov-stock.adobe.com.jpeg
Association Between Hypertensive Disorders of Pregnancy, Cardiovascular Severe Maternal Morbidity During Delivery Hospitalization

October 3rd 2024

Measuring blood pressure | Image credit: Andrey Popov - stock.adobe.com
Stalled Progress in Reducing Black Mortality Rates: The Role of External Causes and COVID-19

September 30th 2024

Woman holding hand to heart in pain | Image credit: eddows – stock.adobe.com
Largest Study of Lp(a), Recurrent ASCVD Highlights Critical Risks and Need for Screening

September 24th 2024

DNA double helix | Image credit: Dr_Microbe – stock.adobe.com
The Role of Genetics in Cholesterol, Heart Disease Risk

September 24th 2024

Advancements in Population Health Strategies for Cardiovascular Risk Management

Experts discuss how lipoproteins drive atherosclerotic heart disease, review the different guidelines and recommendations on Lp(a) testing, and insights from clinical trials.

Hands holding a heart with a heartbeat on it and the words AJMC Insights
Continuing Medical Education
View All
October 13th 2024

Advances and Best Practices for Managed Care Pharmacists in the Treatment of Heart Failure with Preserved Ejection Fraction

1.0 Credits / Cardiology
October 13th 2024

Exploring Transthyretin-Mediated Amyloidosis and Its Phenotypes: A Comprehensive Approach to Patient Treatment

1.5 Credits / Cardiology, Neurology, Rare Diseases
October 13th 2024

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

More News

FDA Approved | Image Credit: Lia Aramburu – stock.adobe.com
November 10th 2023

FDA Approves Recor Medical's Paradise Ultrasound Renal Denervation System

Patrick Campbell
Recor Medical announced the FDA approval of its Paradise Ultrasound Renal Denervation system for the treatment of hypertension on November 7, 2023.
LDL cholesterol chart | Image credit: Vitalii Vodolazskyi - stock.adobe.com
November 6th 2023

Rates of Elevated LDL-C Have Decreased, but Awareness, Treatment Still Suboptimal

Rose McNulty
The prevalence of severely elevated low-density lipoprotein cholesterol (LDL-C) has declined in recent decades, but 1 in 17 US adults in a recent analysis had levels of LDL-C that would warrant consideration of pharmacotherapy, and 1 in 48 had high levels of LDL-C that are indicated for medication.
FDA Approves Medtronic’s Extravascular Defibrillator for Ventricular Arrhythmia
October 23rd 2023

FDA Approves Medtronic’s Extravascular Defibrillator for Ventricular Arrhythmia

Connor Iapoce
The first-of-its-kind Aurora EV-ICD system offers a single-device, single procedure with a lead placed outside of the heart and veins.
Pregnant woman consulting with doctor | Image Credit: pressmaster – stock.adobe.com
October 21st 2023

Study Highlights BMI, Adverse Pregnancy Outcomes as Markers for CVD Risk

Hayden E. Klein
Researchers noted that adverse pregnancy outcomes are more of an indicator of pre-pregnancy cardiovascular risk rather than a primary cause of postpartum risk.
Red heart with stethoscope | Image Credit: © eggeeggjiew - stock.adobe.com
October 19th 2023

Million Hearts Payment Model Shows Prevention of CVD Outcomes Without Increasing Spending

Christina Mattina
A 5-year randomized trial showed that the Million Hearts Model, which paid health care organizations to monitor and reduce cardiovascular disease (CVD) risk, was effective in reducing first-time heart attacks and strokes without associated increases in Medicare spending.
What We’re Reading: Novavax Ships Updated COVID-19 Vaccine; Cardiovascular-Kidney-Metabolic Syndrome; Walgreens Walkout
October 10th 2023

What We’re Reading: Novavax Ships Updated COVID-19 Vaccine; Cardiovascular-Kidney-Metabolic Syndrome; Walgreens Walkout

AJMC Staff
Updated vaccines are on their way to US pharmacies; importance of early diagnosis and treatment for individuals at risk of cardiovascular disease; Walgreens pharmacists stage their own protest.
doctor taking patient's blood pressure | Image Credit: Pixel-Shot – stock.adobe.com
October 6th 2023

High Blood Pressure in Adolescence Increases Cardiovascular Event Risk, Study Finds

Connor Iapoce
An analysis of more than 1 million men found higher blood pressure in late adolescence was associated with an increased risk for major cardiovascular events in later life.
Alaska totem pole | Image credit: Maridav – stock.adobe.com
September 29th 2023

CVD Burden Higher Among American Indian, Alaska Native Medicare Beneficiaries

Hayden E. Klein
The cohort study focused on annual incidence, prevalence, and mortality linked to a number of cardiovascular conditions between 2015 and 2019.
Doctor taking pregnant woman's blood pressure | Image credit: interstid – stock.adobe.com
September 27th 2023

USPSTF Updates Guidance on Screening for Hypertensive Disorders of Pregnancy

Patrick Campbell
In their latest recommendation statement, the US Preventive Services Task Force (USPSTF) recommends blood pressure screening for all pregnant individuals to detect hypertensive disorders.
black history | Image credit: freshidea – stock.adobe.com
September 12th 2023

Data Show Clear Racial Disparities in Obesity-Related Cardiovascular Deaths

Hayden E. Klein
Over the past 20 years, the age-adjusted mortality rate for obesity-related cardiovascular mortality increased by 415% for American Indian or Alaska Native individuals.
Health care workers collaborating | Image credit: Наталья Евтехова – stock.adobe.com
September 8th 2023

Shared Decision-Making Is Missing From Many Cardiovascular Guidelines, Analysis Says

Hayden E. Klein
Across 65 cardiovascular guidelines with nearly 7500 specific recommendations published 2012-2022, only 170 recommendations directly incorporated shared decision-making.
Global Burden of Atrial Fibrillation Rises Sharply Over 30 Years, Study Finds
August 31st 2023

Global Burden of Atrial Fibrillation Rises Sharply Over 30 Years, Study Finds

Mary Caffrey
The authors found shifting patterns in the effects of obesity, alcohol, and smoking on atrial fibrillation.
A black women who is sad
August 30th 2023

More Black vs White Patients Have Risk Factors for LV Hypertrophy

Maggie L. Shaw
Investigators conducted this subanalysis among patients aged 20 to 27 years, using data from the National Growth and Health Study to determine potential racial differences in left ventricular mass among female patients with obesity.
person smoking e-cigarette
August 17th 2023

E-Cigarette Use Among Adults With CVD Increased During COVID-19 After Years of Decline

Hayden E. Klein
The decrease in e-cigarette use between 2014 and 2019 may be linked to improved education on the harms of the devices, while the increase in 2019 could be attributed to worsened psychological burden during the COVID-19 pandemic.
stethoscope around a heart on a blue background
August 14th 2023

Contributor: The Connection Between Gout and CVD Requires Cross-Specialty Collaboration

Ambrose Panico, DO Brittany Panico, DO
The Panicos are on a mission to change how we think about gout. Why? As a husband-and-wife DO duo, the Panicos each have a unique perspective on gout and how physicians in their respective fields can better collaborate to help patients who live with this systemic disease.
Stephen Nicholls
August 10th 2023

Dr Stephen Nicholls: How a Cardiovascular Trial Addresses Long-Term Practicality of GLP-1–Based Weight Loss

Maggie L. Shaw Mary Caffrey
Stephen Nicholls, PhD, MBBS, Monash University and Victorian Heart Hospital, explains how he works closely with patients and study sites in SURPASS-CVOT to avoid weight loss drug discontinuation and weight regain.
pregnant woman
August 9th 2023

Certain Fertility Treatments Do Not Increase CVD Risk for Mothers, Study Says

Hayden E. Klein
New research shows that in vitro fertilization with or without intracytoplasmic sperm injection and the use of fresh or frozen embryo transfers were not associated with an increased risk of cardiovascular disease (CVD) for the mother.
doctor talking to patient sitting on an exam table
August 4th 2023

Postpartum Cardiovascular Health Counseling Rates May Be Lacking in At-Risk Patients

Hayden E. Klein
Postpartum cardiovascular health counseling dropped slightly from 2016 to 2020, both for individuals with and without cardiovascular disease risk factors.
G.B. John Mancini, MD
August 1st 2023

Dr G. B. John Mancini Details VICTORION-2-PREVENT Trial Recruiting Process

Maggie L. Shaw Hayden E. Klein
G.B. John Mancini, MD, University of British Columbia, goes into detail about the recruitment process of the VICTORION-2-PREVENT trial, which focuses on inclisiran to reduce cardiovascular risk.
Stephen Nicholls, PhD, MBBS
July 28th 2023

How SURPASS-CVOT Spotlights Tirzepatide for Cardiovascular Outcomes: Dr Stephen Nicholls

Maggie L. Shaw Mary Caffrey
Stephen Nicholls, PhD, MBBS, Monash University and Victorian Heart Hospital, expands on the patient characteristics and potential impacts of COVID-19 on SURPASS-CVOT, the phase 3 cardiovascular outcomes trial for tirzepatide.
Clipboard with written prescription statins and stethoscope. | Image Credit: Vitalii Vodolazskyi – stock.adobe.com
July 26th 2023

Daily Pitavastatin Reduces Cardiovascular Risk in People With HIV

Hayden E. Klein
Among people living with HIV receiving antiretroviral therapy, those taking 4-mg pitavastatin daily were 35% less likely than those taking placebo to experience a major cardiovascular event over 5 years of follow-up.
G.B. John Mancini, MD, University of British Columbia
July 22nd 2023

Dr G. B. John Mancini Underscores the Importance of Preventive Cardiology

Maggie L. Shaw
The ASPC Congress on CVD Prevention is taking place in Arlington, Texas, July 21-23. Here, G.B. John Mancini, MD, University of British Columbia, emphasizes the importance of having an international perspective on preventive cardiology.
table full of healthy foods
July 21st 2023

Research Identifies 6 Food Groups With Largest Impact on Cardiovascular Outcomes

Hayden E. Klein
After replicating the PURE study, researchers found that individuals with higher PURE diet scores had lower risk of death, cardiovascular disease, myocardial infarction, and stroke.
middle aged 40s or 50s happy and attractive woman with grey hair training at city park with green trees on sunrise doing running and jogging workout in health care | Image Credit: TheVisualsYouNeed – stock.adobe.com
July 18th 2023

Concentrated Exercise Reduces Cardiovascular Risk Similarly to Distributed Exercise

Hayden E. Klein
Research suggests that intense physical activity concentrated within 1-2 days and activity more evenly distributed activity across several days are associated with similarly lower risk of cardiovascular outcomes.
WWR logo
July 13th 2023

What We’re Reading: OTC Birth Control Pill Approval; Medicare Challenged; Redlining, Worse Heart Health Linked

AJMC Staff
The FDA has approved the first over the counter (OTC) birth control pill Thursday; the US Chamber of Commerce has filed a motion for preliminary injunction on the Medicare Drug Price Negotiation program; individuals living in historically redlined areas are likely to have worse heart health.
stethoscope wrapped around globe
July 13th 2023

New Global Analysis Reveals Wide Variation in Lipid-Associated CVD Risk

Hayden E. Klein
Research was conducted by multiple laboratories in the Global Diagnostics Network and included more than 460 million lipid test results from 17 countries to determine risk of cardiovascular disease (CVD).
Non-Statin Therapies for Patients at High Risk for Cardiovascular Disease
March 31st 2023

Non-Statin Therapies for Patients at High Risk for Cardiovascular Disease

Erin Michos, MD, MHS, opens a discussion surrounding the utilization of bempedoic acid for patients with intolerance to statin-based therapies.
Heart.
July 25th 2022

Risk of Myocardial Infarction Greater Among Patients With Hidradenitis Suppurativa

Matthew Gavidia
An increased risk of developing myocardial infarction was observed among patients with hidradenitis suppurativa (HS), whereas risk of cerebrovascular accident and peripheral vascular disease was comparable between those with HS and controls.
Treatment Disparities in the Management of ASCVD
May 31st 2022

Treatment Disparities in the Management of ASCVD

Dr Slipczuk concludes our discussion by detailing healthcare disparities commonly seen within ASCVD treatment.
Improving Patient and Provider Engagement
May 31st 2022

Improving Patient and Provider Engagement

A cardiology expert considers the future of lipid management within health systems and ways they can improve engagement from all parties.
<12345678
...
22>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo